|
FOR
IMMEDIATE RELEASE
February 2, 2022
Contact: CMS Media Relations
CMS Media Inquiries
CMS Releases 2023 Medicare
Advantage and Part D Advance Notice
Agency seeks input on promoting health equity in Medicare
Advantage and Part D plans
Today,
the Centers for Medicare & Medicaid Services (CMS) released proposed
payment policy changes for Medicare Advantage and Part D drug programs
in 2023 that will create more choices and provide affordable options
for consumers that meet their unique health needs. The Calendar Year
(CY) 2023 Advance Notice for Medicare Advantage (MA) and Part D plans
is open to public comment for 30 days. This year, CMS is specifically
soliciting input through a health equity lens on the approach to some
future potential changes.
“Our
goals for Medicare Advantage mirror our vision for CMS’ programs as a
whole, which is to advance health equity; drive comprehensive,
person-centered care; and promote affordability and the sustainability
of the Medicare program,” said CMS Administrator Chiquita
Brooks-LaSure. “Today’s Advance Notice is one tool to engage our
Medicare Advantage and Part D plan partners, and the communities we
serve, as we work toward these goals.”
CMS
is requesting input on a potential change to the MA and Part D Star
Ratings that would take into account how well each plan advances health
equity. CMS is also requesting comment on including a quality measure
in MA and Part D Star Ratings that would specifically assess how often
plans are screening for common health-related social needs, such as
food insecurity, housing insecurity, and transportation problems.
“The
Health Equity Index we seek comment on would enhance the Star Ratings
program, creating transparency on how Medicare Advantage plans care for
our most disadvantaged beneficiaries, and providing an opportunity to
encourage improvements in their care,” said CMS Deputy Administrator
and Director of the Center for Medicare Meena Seshamani, MD, PhD. “We
are looking for input from our community and partners on this index,
which would keep with our commitment to transparency and follow our
guiding principle to advance health equity.”
Additionally,
CMS is requesting input on considerations for assessing the impact of
using sub-state geographic levels of rate setting for enrollees with
end stage renal disease, particularly input regarding the impact of MA
payment on care provided to rural and urban underserved populations and
how such payment changes may impact health equity.
Other
areas that CMS is soliciting input on include a variety of payment
updates; a new measure concept to assess whether and how MA plans are
transforming care by engaging in value-based models with providers; and
updates to risk adjustment models to continue to pay appropriately for
the people enrolled in MA and Part D plans.
Public
comments on the Advance Notice must be submitted by March 4, 2022. The
Medicare Advantage and Part D payment policies for 2023 will be
finalized in the 2023 Rate Announcement, which will be published no
later than April 4, 2022.
For
a fact sheet on the 2023 Advance Notice, please visit: https://www.cms.gov/newsroom/fact-sheets/2023-medicare-advantage-and-part-d-advance-notice-fact-sheet
To
view the 2023 Advance Notice, please visit: https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Announcements-and-Documents.html
and select “2023.”
###
Get CMS news at cms.gov/newsroom, sign up for CMS news
via email and follow CMS on Twitter @CMSgov
|
No comments:
Post a Comment